KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Hims & Hers Health (HIMS) Long-Term Deferred Tax (2024 - 2026)

Hims & Hers Health's Long-Term Deferred Tax history spans 3 years, with the latest figure at $92.1 million for Q1 2026.

  • On a quarterly basis, Long-Term Deferred Tax rose 47.36% to $92.1 million in Q1 2026 year-over-year; TTM through Mar 2026 was $92.1 million, a 47.36% increase, with the full-year FY2025 number at $82.7 million, up 34.26% from a year prior.
  • Long-Term Deferred Tax hit $92.1 million in Q1 2026 for Hims & Hers Health, up from $82.7 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for HIMS hit a ceiling of $92.1 million in Q1 2026 and a floor of $54.3 million in Q3 2024.
  • Historically, Long-Term Deferred Tax has averaged $74.6 million across 3 years, with a median of $82.7 million in 2025.
  • The widest YoY moves for Long-Term Deferred Tax: up 56.35% in 2025, down 34.26% in 2025.
  • Tracing HIMS's Long-Term Deferred Tax over 3 years: stood at $61.6 million in 2024, then soared by 34.26% to $82.7 million in 2025, then increased by 11.35% to $92.1 million in 2026.
  • Business Quant data shows Long-Term Deferred Tax for HIMS at $92.1 million in Q1 2026, $82.7 million in Q4 2025, and $84.9 million in Q3 2025.